Denosumab versus zoledronic acid for patients with beta-thalassemia major-induced osteoporosis

por Yassin, Mohamed A., Abdel Rahman, Mohamed O., Hamad, Anas A., Poil, Abdul Razzakh, Abdelrazek, Mohamed T., Hussein, Radwa M., Kassem, Nancy A., Fadul, Afraa M., Elkourashy, Sarah A., Nashwan, Abdulqadir J.
Publicado 2020